AIDP, Inc. announced that it has acquired the core technology and related intellectual property of Olygose SAS (France). This includes the transfer of patents, manufacturing technology, trademarks, but also pre-clinical and clinical studies, regulatory certificates, and other intellectual know-how.

A new study in the journal Diabetes suggests that using probiotics or prebiotics to help correct abnormal gut microbiotia may help type 1 diabetes.